# A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-placebo-controlled-trial-of-pembrolizumab-plus-chemotherapy-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Luis Paz‐Ares,David Vicente,Ali Tafreshi,Andrew Robinson,Héctor Soto Parrà,Julien Mazières,Bárbara Hermes,İrfan Çiçin,Balazs Medgyasszay,Jerónimo Rafael Rodríguez‐Cid,Isamu Okamoto,Sung-Sook Lee,Rodryg Ramlau,Vladimir Vladimirov,Ying Cheng,Xuan Deng,Ying Zhang,Tuba Öcek Baş,Bilal Piperdi,Balázs Halmos |
| Citations | 653 |
| DOI | 10.1016/j.jtho.2020.06.015 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://www.jto.org/article/S1556086420305001/pdf |
| OpenAlex ID | https://openalex.org/W3037506839 |
| PMID | 32599071 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Julien Mazières](https://scholariq.org/researchers/julien-mazieres/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Balázs Halmos](https://scholariq.org/researchers/balazs-halmos/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.